Evolutionary information improves discovery of mutations associated with diseasesContinue reading
Category Archives: AZBio News
Help us say Thank You at the 2012 AZBio Awards
On October 23rd Arizonans will be gathering from throughout the state at the Phoenix Convention Center for the 7th Annual AZBio Awards. In addition to shining a spotlight on the achievements of our industry’s leaders, we will be using this opportunity to show our appreciation to the community that has supported the biosciences over the years. The distance we have travelled isn’t merely measured in industry achievements. Every Arizonan has contributed to our progress; either directly, as an innovator, researcher, leader, or investor, or indirectly as Arizona voters and taxpayers.Continue reading
Yulex Corp and Cooper Tire Receive $6.9 Million USDA Grant
Grant will fund guayule bio-based, next-generation tire developmentContinue reading
Washington Run Down – July 2012
As a member of the CSBA (Council of State Bioscience Associations), AZBio receives a monthy run down of the latest news from our nation’s capitol.
Here is the latest Washington Update from BIO and the C2Group. Continue reading
FDA Comment Request: Establishing a unique device identification system for medical devices
The Food and Drug Administration (FDA) is proposing to establish a unique device identification system to implement the requirement added to the Federal Food, Drug, and Cosmetic Act (FD&C Act) by section 226 of the Food and Drug Administration Amendments Act of 2007 (FDAAA), Section 226 of FDAAA amended the FD&C Act to add new section 519(f), which directs FDA to promulgate regulations establishing a unique device identification system for medical devices. Continue reading
Supreme Court Obamacare Ruling Fast Tracks Healthcare Issues
A Guest Post By Larry Aldrich, Executive Director, Arizona Business Coalition on HealthContinue reading
Biochemist awarded ASU’s coveted Galvin Professorship
An expert in the structural biochemistry and biophysics of membrane proteins, ASU’s Galvin Professor Petra Fromme’s research efforts and multi-institution team are revolutionizing core understanding about infectious disease and creating exciting developments in medicine and clean energy. Continue reading
Comments Needed: SBA Releases Proposed SBIR & STTR Regulations
SBIR Inside Track: SBA Releases Proposed SBIR & STTR Regulations. Open for Public Comment Until July 16, 2012Continue reading
Flagship Sails Into New Waters With Expansion Into Neuroscience Pathology Services
Flagship Biosciencs expands quantitative histopathology services into neurodegenerative disease and neurotoxicity
Stereological and classical image analysis approaches help to more accurately quantify neuropathology and model treatment efficacyContinue reading
Performing Under PDUFA: The FDA Wants to Hear From You
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the statement of work for an assessment of the Program for Enhanced Review Transparency and Communication for New Molecular Entity (NME) New Drug Applications (NDAs) and Original Biologics License Applications (BLAs) (the Program). Continue reading